Ash Access Technology (United States)

A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: A multi-center, controlled, randomized trial*

Dennis G. Maki, Stephen R. Ash, Roland K. Winger et al. · Critical Care Medicine · 2011 · 121 citations

Medicine, Nephrology, Pharmacotherapy +17

Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions

Karin Sauer, Janusz Steczko, Stephen R. Ash · Journal of Antimicrobial Chemotherapy · 2009 · 51 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens)

Janusz Steczko, Stephen R. Ash, David E. Nivens et al. · Nephrology Dialysis Transplantation · 2009 · 41 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Clinical and Regulatory Considerations for Central Venous Catheters for Hemodialysis

Douglas M. Silverstein, Scott O. Trerotola, Timothy W.I. Clark et al. · Clinical Journal of the American Society of Nephrology · 2018 · 31 citations · Full text

Medicine, Biomedical Engineering, Nephrology +13

Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trials

Simon D. Roger, Bruce Spinowitz, Edgar V. Lerma et al. · Nephrology Dialysis Transplantation · 2020 · 25 citations · Full text

Medicine, Nephrology, Pharmacology +15